Cellular energetic metabolism of cerebral tissue: Metabolic characteristics of glial tumours;Métabolisme énergétique cellulaire du tissu cérébral: Spécificités métaboliques des tumeurs gliales

Annales de Biologie Clinique

Volumn 66, Issue 2, 2008, Pages 131-141

  La Schiazza, R ^a   Lamari, F ^a   Foglietti, M J ^b   Hainque, B ^a,b   Bernard, M ^a,b   Beaudeux, J L ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Brain tissue; Cellular co operation; Energetic metabolism; Gliomas; Warburg effect

Indexed keywords

GLUCOSE; LACTIC ACID DERIVATIVE;

ADULT; AGE; ANIMAL; ASTROCYTE; BRAIN; BRAIN TUMOR; CANCER STAGING; CHILD; COMPARATIVE STUDY; DISEASE MODEL; ENERGY METABOLISM; GENETICS; GLIOMA; GLYCOLYSIS; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; REVIEW;

ADULT; AGE FACTORS; ANIMALS; ASTROCYTES; BRAIN; BRAIN NEOPLASMS; CHILD; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLIOMA; GLUCOSE; GLYCOLYSIS; HUMANS; LACTATES; METABOLISM; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NEOPLASM STAGING;

EID: 42449083778     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2008.0205     Document Type: Review

References (62)

1. Qutub AA, Hunt CA. Glucose transport to the brain : a systems model. Brain Res Brain Res Rev 2005 ; 49 : 595-617.
2. Barros LF, Porras OH, Bittner CX. Why glucose transport in the brain matters for PET. Trends Neurosci 2005 ; 28 : 117-9.
3. Pardridge WM. Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann N Y Acad Sci 1993 ; 692 : 126-37.
4. Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD. Basic neurochemistry : molecular, cellular and medical aspects. 6th Edition. Hagerstown : Lippincott Williams & Wilkins, 1998.
5. Allaman I, Pellerin L, Magistretti PJ. Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes. J Neurochem 2004 ; 88 : 900-8.
6. Dalsgaard MK. Fuelling cerebral activity in exercising man. J Cereb Blood Flow Metab 2006 : 731-50.
7. Lebon V, Petersen KF, Cline GW, et al. Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy : elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 2002 ; 22 : 1523-31.
8. Magistretti PJ, Pellerin L. Regulation by neurotransmitters of glial energy metabolism. Adv Exp Med Biol 1997 ; 429 : 137-43.
9. Aubert A, Costalat R, Magistretti PJ, Pellerin L. Brain lactate kinetics : modeling evidence for neuronal lactate uptake upon activation. Proc Natl Acad Sci USA 2005 ; 102 : 16448-53.
10. Aubert A, Costalat R. Interaction between astrocytes and neurons studied using a mathematical model of compartmentalized energy metabolism. J Cereb Blood Flow Metab 2005 ; 25 : 1476-90.
11. Bouzier-Sore AK, Voisin P, Canioni P, Magistretti PJ, Pellerin L. Lactate is a preferential oxidative energy substrate over glucose for neurons in culture. J Cereb Blood Flow Metab 2003 ; 23 : 1298-306.
12. Pellerin L, Magistretti PJ. Neuroenergetics ; calling upon astrocytes to satisfy hungry neurons. Neuroscientist 2004 ; 10 : 53-62.
13. Bittar PG, Charnay Y, Pellerin L, Bourras C, Magistretti PJ. Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J Cereb Blood Flow Metab 1996 ; 16 : 1079-89.
14. Dienel GA, Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia 2005 ; 50: 362-88.
15. Magnani M, Crinelli R, Antonelli A, Casablanca A, Serafini G. The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system. Biochim Biophys Acta 1994 ; 1206 : 180-90.
16. Miccoli L, Oudard S, Sureau F, Poirson F, Dutrillaux B, Poupon MF. Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochem J 1996 ; 313 : 957-62.
17. Bolanos JP, Cidad P, Garcia-Nogales P, Delgado-Esteban M, Fernandez E, Almeida A. Regulation of glucose metabolism by nitrosative stress in neural cells. Mol Aspects Med 2004 ; 25 : 61-73.
18. Seyfried TN, Mukherjee P. Targeting energy metabolism in brain cancer : review and hypothesis. Nutr Metab 2005 ; 2 : 30.
19. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 2001 ; 15 : 1406-18.
20. Qian Y, Zheng Y, Abraham L, Ramos KS, Tiffany-Castiglioni E. Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells. Brain Res Mol Brain Res 2005 ; 134 : 323-32.
21. Almeida A, Cidad P, Delgado-Esteban M, Fernandez E, Garcia-Nogales P, Bolanos JP. Inhibition of mitochondrial respiration by nitric oxide : its role in glucose metabolism and neuroprotection. J Neurosci Res 2005 ; 79: 166-71.
22. DeAngelis LM. Brain tumors. N Engl J Med 2001 ; 344 : 114-23.
23. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors : current concepts and review of the literature. Neuro-oncol 2002 ; 4 : 278-99.
24. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003 ; 361 : 323-31.
25. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 2005 ; 7 : 134-53.
26. Elstrom RL, Bauer DE, Buzzai M, et al. Thompson CB. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004 ; 64 : 3892-9.
27. Knobbe CB, Merlo A, Reifenberger G. Pten signaling in gliomas. Neuro Oncol 2002 ; 4 : 196-211.
28. Nozaki M, Tada M, Kobayashi H, et al. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Neuro Oncol 1999 ; 1 : 124-37.
29. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999 ; 24 : 68-72.
30. Beckner ME, Gobbel GT, Abounader R, et al. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Lab Invest 2005 ; 85 : 1457-70.
31. Gorin F, Harley W, Schnier J, Lyeth B, Jue T. Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft. Acta Neuropathol (Berl) 2004 ; 107 : 235-44.
32. Boado RJ, Black KL, Pardridge WM. Gene expression of GLUT3 and GLUTI glucose transporters in human brain tumors. Brain Res Mol Brain Res 1994 ; 27 : 51-7.
33. Nagamatsu S, Nakamichi Y, Inoue N, Inoue M, Nishino H, Sawa H. Rat C6 glioma cell growth is related to glucose transport and metabolism. Biochem J 1996 ; 319 : 477-82.
34. Burrows RC, Freeman SD, Charlop AW, et al. [18F]-2-fluoro-2- deoxyglucose transport kinetics as a function of extracellular glucose concentration in malignant glioma, fibroblast and macrophage cells in vitro. Nucl Med Biol 2004 ; 31 : 1-9.
35. Sanchez-Alvarez R, Tabernero A, Medina JM. The increase in gap junctional communication decreases the rate of glucose uptake in C6 glioma cells by releasing hexokinase from mitochondria. Brain Res 2005 ; 1039 : 189-98.
36. Ziegler A, Von Kienlin M, Decorps M, Remy C. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res 2001 ; 61 : 5595-600.
37. Mies G, Paschen W, Ebhardt G, Hossmann KA. Relationship between of blood flow, glucose metabolism, protein synthesis, glucose and ATP content in experimentally-induced glioma (RG1 2.2) of rat brain. J Neurooncol 1990 ; 9 : 17-28.
38. Oudard S, Boitier E, Miccoli L, Rousset S, Dutrillaux B, Poupon MF. Mitochondria-bound hexokinase as target for therapy of malignant gliomas. Int J Cancer 1995 ; 62 : 216-22.
39. Oudard S, Arvelo F, Miccoli L, et al. Gliomas are driven by glycolysis : putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. Anticancer Res 1997 ; 17 : 1903-11.
40. Oudard S, Arvelo F, Miccoli L, et al. High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. Br J Cancer 1996 ; 74 : 839-45.
41. Berger MS, Prados MD. Textbook of Neuro-Oncology. Berlin: Springer, 2005.
42. Rueger MA, Kracht LW, Hilker R, et al. Role of in vivo imaging of the central nervous system for developing novel drugs. Q J Nucl Med Mol Imaging 2007 ; 51 : 164-81.
43. Bouzier-Sore AK, Canioni P, Merle M. Effect of exogenous lactate on rat glioma metabolism. J Neurosci Res 2001 ; 65 : 543-8.
44. Mangiardi JR, Yodice P. Metabolism of the malignant astrocytoma. Neurosurgery 1990 ; 26 : 1-19.
45. Oude Weernink PA, Rijksen G, Staal GE. Phosphorylation of pyruvate kinase and glycolytic metabolism in three human glioma cell lines. Tumour Biol 1991 ; 12 : 339-52.
46. Wilson JE. Isozymes of mammalian hexokinase : structure, subcellular localization and metabolic function. J Exp Biol 2003 ; 206 : 2049-57.
47. Meixensberger J, Herting B, Roggendorf W, Reichmann H. Metabolic patterns in malignant gliomas. J Neurooncol 1995 ; 24 : 153-61.
48. Lowry OH, Berger SJ, Carter JG, et al. Diversity of metabolic patterns in human brain tumors : enzymes of energy metabolism and related metabolites and cofactors. J Neurochem 1983 ; 41 : 994-1010.
49. rkezaki K, Black KL, Conklin SG, Becker DP. Histochemical evaluation of energy metabolism in rat glioma. Neurol Res 1992 ; 14 : 289-93.
50. Griguer CE, Oliva CR, Gillespie GY. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines. J Neurooncol 2005 ; 74 : 123-33.
51. Rabow L, Kristensson K. Changes in lactate dehydrogenase isoenzyme patterns in patients with tumours of the central nervous system? Acta Neurochir (Wien) 1977 ; 36 : 71-81.
52. Lichtor T, Dohrmann GJ. Respiratory patterns in human brain tumors. Neurosurgery 1986 ; 19 : 896-9.
53. Dmitrenko V, Shostak K, Boyko O, et al. Reduction of the transcription level of the mitochondrial genome in human glioblastoma. Cancer Lett 2005 ; 218 : 99-107.
54. Wink MR, Lenz G, Braganhol E, et al. Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett 2003 ; 198 : 211-8.
55. Beckner ME, Gobbel GT, Abounader R, et al. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Lab Invest 2005 ; 85 : 1457-70.
56. Pu P, Kang C, Li J, Jiang H, Cheng J. The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. J Neurooncol 2006 ; 76 : 1-11.
57. Guha A, Mukherjee J. Advances in the biology of astrocytomas. Curr Opin Neurol 2004 ; 17 : 655-62.
58. Derlon JM, Cabal P, Blaizot X, Borha A, Chapon F. Metabolic imaging for supratentorial oligodendrogliomas. Neurochirurgie 2005 ; 51 : 309-22.
59. Muzi M, Freeman SD, Burrows RC, et al. Kinetic characterization of hexokinase isoenzymes from glioma cells : implications for FDG imaging of human brain tumors. Nucl Med Biol 2001 ; 28 : 107-16.
60. Padma MV, Said S, Jacobs M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 2003 ; 64 : 227-37.
61. Sasajima T, Miyagawa T, Oku T, Gelovani JG, Finn R, Blasberg R. Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines. Eur J Nucl Med Mol Imaging 2004 ; 31 : 1244-56.
62. Mazurek S, Boschek CB, Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 1997 ; 29 : 315-30.